Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasisYun Zhang, Robert A. Weinberg, Ferenc Reinhardt et al.|Nature Cell Biology|2022Cited by 130
Abstract PR05: Loss of PRC2 or KMT2D-COMPASS generates two quasi-mesenchymal cell states with distinct metastatic abilitiesYun Zhang, Robert A. Weinberg, Joana Liu Donaher et al.|Cancer Research|2020Cited by 0